Product Information
TIZANIDINE HCL 4 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0918 per EA under NDC 67877061115. Its NADAC has been published 339 times since Jan 1, 2020.
Strength
4 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877061115
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TIZANIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212196On Market Since
3/29/2019
Pharmacological Classes
Price Statistics
The NADAC for TIZANIDINE HCL 4 MG CAPSULE has been published 339 times since Jan 1, 2020, and over the history we have for it it has declined 84.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0918 per EA |
|---|---|
| All-time high | $0.5962 (Jan 15, 2020) |
| All-time low | $0.0827 (May 22, 2024) |
| 52-week high | $0.1250 |
| 52-week low | $0.0846 |
| Median price | $0.1445 |
| Average price | $0.1775 |
| Largest weekly change | +94.5% (Jun 23, 2021) |
| Weeks tracked | 339 |
| Tracking since | Jan 1, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Tizanidne hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TIZANIDINE HCL 4 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 4 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.0918 per EA (NDC 67877061115), effective Jun 24, 2026.
How has the price of TIZANIDINE HCL 4 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has declined 84.6%. It has been tracked across 339 weekly CMS publications since Jan 1, 2020.
What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 4 MG CAPSULE?
Since Jan 1, 2020, the NADAC for TIZANIDINE HCL 4 MG CAPSULE has ranged from a low of $0.0827 (May 22, 2024) to a high of $0.5962 (Jan 15, 2020), with a median of $0.1445 per EA.
Are there cheaper alternatives to TIZANIDINE HCL 4 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TIZANIDINE HCL 4 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures TIZANIDINE HCL 4 MG CAPSULE?
TIZANIDINE HCL 4 MG CAPSULE (NDC 67877061115) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification